Journal of Neurogastroenterology and Motility : eISSN 2093-0887 / pISSN 2093-0879

Table. 3.

Comparison of Clinical Factors Between Proton Pump Inhibitor and Swallowed Topical Steroid Therapies as First Therapy

Clinical factors PPI (n = 27) STS (n = 7) P-value
Age (yr) > 0.999
< 40 7 (25.9) 1 (14.3)
≥ 40 20 (74.1) 6 (85.7)
Sex 0.644
Male 19 (70.4) 6 (85.7)
Female 8 (29.6) 1 (14.3)
Allergic disease > 0.999
None 18 (66.7) 5 (71.4)
Present 9 (33.3) 2 (28.6)
Esophageal symptoms
Dysphagia 12 (44.4) 4 (57.1) 0.681
Heartburn 7 (25.9) 2 (28.6) > 0.999
Pain 4 (14.8) 2 (28.6) 0.580
Globus 1 (3.7) 0 (0.0) > 0.999
Food impaction 2 (7.4) 0 (0.0) > 0.999
Endoscopic features
Edema 15 (55.6) 1 (14.3) 0.090
Rings 9 (33.3) 4 (57.1) 0.387
Exudates 3 (11.1) 2 (28.6) 0.268
Furrows 16 (59.3) 3 (42.9) 0.672
Stricture 1 (3.7) 3 (42.9) 0.021

PPI, proton pump inhibitor; STS, swallowed topical steroid.

Data are presented as n (%).

J Neurogastroenterol Motil 2021;27:71~77 https://doi.org/10.5056/jnm20069
© J Neurogastroenterol Motil